世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のヒト血清アルブミン市場レポート、歴史と予測 2018-2029


Global Human Serum Albumin Market Report, History and Forecast 2018-2029

COVID-19パンデミックとロシア・ウクライナ戦争の影響により、ヒト血清アルブミンの世界市場は2022年に5110百万米ドルと推定され、2029年までに8369百万米ドルの修正規模に達し、予測期間2023年から2029年にかけ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年3月10日 US$3,350
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

COVID-19パンデミックとロシア・ウクライナ戦争の影響により、ヒト血清アルブミンの世界市場は2022年に5110百万米ドルと推定され、2029年までに8369百万米ドルの修正規模に達し、予測期間2023年から2029年にかけてCAGR 7.27%で成長すると予測されています。
ヒト血清アルブミンの北米市場は、2022年に6億5100万ドルで、2023年から2029年の予測期間中に6.07%のCAGRで、2029年までに9億8600万ドルに達すると予測されます。
ヒト血清アルブミンのアジア太平洋市場は、2022年に3億5,000万ドルと評価され、2023年から2029年の予測期間中にCAGR 7.71 %で、2029年までに5億8,900万ドルに達する見込みです。
ヒト血清アルブミンのヨーロッパ市場は、2022年に7億2900万ドルと評価され、2023年から2029年の予測期間中にCAGR 6.11 %で、2029年までに1億1300万ドルに達する見込みです。

レポートスコープ
当レポートは、ヒト血清アルブミンの世界市場を量的および質的分析により包括的に提示し、読者がビジネス/成長戦略の策定、市場競争状況の評価、現在の市場における自社のポジションを分析し、ヒト血清アルブミンに関するビジネス上の意思決定を行うための一助とすることを目的としています。
ヒト血清アルブミンの市場規模、推計、予測は、2022年を基準年とみなし、2018年から2029年までの期間の履歴と予測データを、販売量(MT)および収益(百万ドル)で提供しています。本レポートでは、世界のヒト血清アルブミン市場を包括的に区分しています。タイプ別、アプリケーション別、プレイヤー別の製品に関する地域別の市場規模も掲載しています。市場規模を推定する際に、COVID-19とロシア・ウクライナ戦争の影響を考慮しました。

市場をより深く理解するために、本レポートでは、競争環境、主要な競合他社のプロフィール、それぞれの市場ランクを紹介しています。また、技術動向や新製品開発についても解説しています。
本レポートは、読者が潜在的な利益を高めるために、業界内の競争と競争環境に対する戦略を理解するのに役立つことでしょう。また、世界のヒト血清アルブミン市場の競争環境に焦点を当て、主要企業の市場シェア、業界ランキング、競合のエコシステム、市場実績、新製品開発、経営状況、拡張、買収などを詳細に紹介し、読者が主要な競合企業を特定し、市場の競争パターンを深く理解するのに役立つ。

市場セグメンテーション
本レポートでは、ヒト血清アルブミンをメーカー別、タイプ別、用途別、地域別、国別に分類し、2022年を基準年とした過去と予測期間(2018-2022、2023-2029)の市場規模(金額、数量、平均価格)およびCAGRを示しています。さまざまなセグメントにおける潜在的な収益機会を解明し、この市場に対する魅力的な投資提案のマトリクスを解説しています。

会社別
グリフォルス
シーエスエル
武田
オクタファーマ
CBPO
花蘭咲バイオ
ケドリオン
上海RAAS
LFBグループ
ビオテスト
ティアンタンバイオ
シュアンリン・バイオ
ボヤバイオ
ユアンダ シュウヨウ
ウェイグァン バイオ

タイプ別セグメント
5%濃縮
20-25% 濃縮

用途別セグメント
賦形剤
治療薬
その他

地域別
北アメリカ
ユーエスエー
カナダ
メキシコ

アジア太平洋
中国
日本
南朝鮮
インド
オーストラリア
東南アジア

ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア

南米
ブラジル

中近東・アフリカ
中近東
アフリカ

コアチャプター
第一章:本レポートの調査範囲、タイプ別市場セグメントのエグゼクティブサマリー、北米、欧州、アジア太平洋、南米、中東・アフリカの市場規模セグメントを紹介します。
第二章:ヒト血清アルブミンメーカーの競争環境、価格、販売、収益、市場シェアとランキング、最新の開発計画、合併、買収情報などの詳細分析。
第3章ヒト血清アルブミンの地域レベルでの販売、収益。各地域の市場規模や発展性を定量的に分析し、今後の発展展望、世界における市場空間などを紹介しています。
第四章:アプリケーション別の市場セグメントを紹介し、北米、欧州、アジア太平洋、南米、中東・アフリカの市場規模セグメントを紹介します。
第5章、第6章、第7章、第8章、第9章:北米、欧州、アジア太平洋、南米、中東&アフリカ、国別の売上と収益。
第10章主要企業のプロフィールを提供し、製品の売上、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本状況を詳しく紹介する。
第11章産業チェーン、主要原材料、製造コスト、市場力学の分析。市場力学、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界における関連政策の分析などを紹介します。
第十二章販売チャネル、流通業者、顧客に関する分析。
第13章:研究成果および結論。


ページTOPに戻る


目次

1 Human Serum Albumin Market Overview 1
1.1 Human Serum Albumin Product Overview 1
1.2 Human Serum Albumin Market by Type 3
1.2.1 5% Concentrations 3
1.2.2 20-25% Concentrations 5
1.3 Global Human Serum Albumin Market Size by Type 6
1.3.1 Global Human Serum Albumin Market Size Overview by Type (2018-2029) 6
1.3.2 Global Human Serum Albumin Historic Market Size Review by Type (2018-2023) 7
1.3.3 Global Human Serum Albumin Forecasted Market Size by Type (2024-2029) 9
1.4 Key Regions Market Size by Type 10
1.4.1 North America Human Serum Albumin Sales Breakdown by Type (2018-2023) 10
1.4.2 Europe Human Serum Albumin Sales Breakdown by Type (2018-2023) 11
1.4.3 Asia-Pacific Human Serum Albumin Sales Breakdown by Type (2018-2023) 13
1.4.4 South America Human Serum Albumin Sales Breakdown by Type (2018-2023) 15
1.4.5 Middle East and Africa Human Serum Albumin Sales Breakdown by Type (2018-2023) 17
2 Human Serum Albumin Market Competition by Company 19
2.1 Global Top Players by Human Serum Albumin Sales (2018-2023) 19
2.2 Global Top Players by Human Serum Albumin Revenue (2018-2023) 20
2.3 Global Top Players by Human Serum Albumin Price (2018-2023) 22
2.4 Global Top Manufacturers Human Serum Albumin Manufacturing Base Distribution, Sales Area, Product Type 23
2.5 Human Serum Albumin Market Competitive Situation and Trends 23
2.5.1 Human Serum Albumin Market Concentration Rate (2018-2023) 23
2.5.2 Global 5 and 10 Largest Manufacturers by Human Serum Albumin Revenue in 2022 24
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum Albumin as of 2022) 25
2.7 Founded Date of Key Human Serum Albumin Manufacturer 26
2.8 Mergers & Acquisitions, Expansion 27
3 Human Serum Albumin Status and Outlook by Region 30
3.1 Global Human Serum Albumin Market Size and CAGR by Region: 2018 VS 2022 VS 2029 30
3.2 Global Human Serum Albumin Historic Market Size by Region 30
3.2.1 Global Human Serum Albumin Sales in Volume by Region (2018-2023) 30
3.2.2 Global Human Serum Albumin Sales in Value by Region (2018-2023) 31
3.2.3 Global Human Serum Albumin Sales (Volume & Value), Price and Gross Margin (2018-2023) 32
3.3 Global Human Serum Albumin Forecasted Market Size by Region 32
3.3.1 Global Human Serum Albumin Sales in Volume by Region (2024-2029) 32
3.3.2 Global Human Serum Albumin Sales in Value by Region (2024-2029) 33
3.3.3 Global Human Serum Albumin Sales (Volume & Value), Price and Gross Margin (2024-2029) 33
4 Human Serum Albumin by Application 34
4.1 Human Serum Albumin Market by Application 34
4.1.1 Excipient 34
4.1.2 Therapeutics 35
4.2 Global Human Serum Albumin Market Size by Application 36
4.2.1 Global Human Serum Albumin Market Size Overview by Application (2018-2029) 37
4.2.2 Global Human Serum Albumin Historic Market Size Review by Application (2018-2023) 39
4.2.3 Global Human Serum Albumin Forecasted Market Size by Application (2024-2029) 40
4.3 Key Regions Market Size by Application 41
4.3.1 North America Human Serum Albumin Sales Breakdown by Application (2018-2023) 41
4.3.2 Europe Human Serum Albumin Sales Breakdown by Application (2018-2023) 42
4.3.3 Asia-Pacific Human Serum Albumin Sales Breakdown by Application (2018-2023) 43
4.3.4 South America Human Serum Albumin Sales Breakdown by Application (2018-2023) 44
4.3.5 Middle East and Africa Human Serum Albumin Sales Breakdown by Application (2018-2023) 45
5 North America Human Serum Albumin by Country 47
5.1 North America Human Serum Albumin Historic Market Size by Country 47
5.1.1 North America Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 47
5.1.2 North America Human Serum Albumin Sales in Volume by Country (2018-2023) 47
5.1.3 North America Human Serum Albumin Sales in Value by Country (2018-2023) 48
5.2 North America Human Serum Albumin Forecasted Market Size by Country 48
5.2.1 North America Human Serum Albumin Sales in Volume by Country (2024-2029) 48
5.2.2 North America Human Serum Albumin Sales in Value by Country (2024-2029) 49
6 Europe Human Serum Albumin by Country 50
6.1 Europe Human Serum Albumin Historic Market Size by Country 50
6.1.1 Europe Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 50
6.1.2 Europe Human Serum Albumin Sales in Volume by Country (2018-2023) 50
6.1.3 Europe Human Serum Albumin Sales in Value by Country (2018-2023) 51
6.2 Europe Human Serum Albumin Forecasted Market Size by Country 52
6.2.1 Europe Human Serum Albumin Sales in Volume by Country (2024-2029) 52
6.2.2 Europe Human Serum Albumin Sales in Value by Country (2024-2029) 53
7 Asia-Pacific Human Serum Albumin by Region 54
7.1 Asia-Pacific Human Serum Albumin Historic Market Size by Region 54
7.1.1 Asia-Pacific Human Serum Albumin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 54
7.1.2 Asia-Pacific Human Serum Albumin Sales in Volume by Region (2018-2023) 54
7.1.3 Asia-Pacific Human Serum Albumin Sales in Value by Region (2018-2023) 55
7.2 Asia-Pacific Human Serum Albumin Forecasted Market Size by Region 56
7.2.1 Asia-Pacific Human Serum Albumin Sales in Volume by Region (2024-2029) 56
7.2.2 Asia-Pacific Human Serum Albumin Sales in Value by Region (2024-2029) 57
8 South America Human Serum Albumin by Country 58
8.1 South America Human Serum Albumin Historic Market Size by Country 58
8.1.1 South America Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 58
8.1.2 South America Human Serum Albumin Sales in Volume by Country (2018-2023) 58
8.1.3 South America Human Serum Albumin Sales in Value by Country (2018-2023) 59
8.2 South America Human Serum Albumin Forecasted Market Size by Country 59
8.2.1 South America Human Serum Albumin Sales in Volume by Country (2024-2029) 59
8.2.2 South America Human Serum Albumin Sales in Value by Country (2024-2029) 60
9 Middle East and Africa Human Serum Albumin by Country 61
9.1 Middle East and Africa Human Serum Albumin Historic Market Size by Country 61
9.1.1 Middle East and Africa Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 61
9.1.2 Middle East and Africa Human Serum Albumin Sales in Volume by Country (2018-2023) 61
9.1.3 Middle East and Africa Human Serum Albumin Sales in Value by Country (2018-2023) 62
9.2 Middle East and Africa Human Serum Albumin Forecasted Market Size by Country 62
9.2.1 Middle East and Africa Human Serum Albumin Sales in Volume by Country (2024-2029) 62
9.2.2 Middle East and Africa Human Serum Albumin Sales in Value by Country (2024-2029) 63
10 Company Profiles 64
10.1 Grifols 64
10.1.1 Grifols Company Information 64
10.1.2 Grifols Introduction and Business Overview 64
10.1.3 Grifols Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 65
10.1.4 Grifols Human Serum Albumin Products Offered 65
10.1.5 Grifols Recent Development 66
10.2 CSL 67
10.2.1 CSL Company Information 67
10.2.2 CSL Introduction and Business Overview 68
10.2.3 CSL Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 68
10.2.4 CSL Human Serum Albumin Products Offered 69
10.2.5 CSL Recent Development 69
10.3 Takeda 70
10.3.1 Takeda Company Information 70
10.3.2 Takeda Introduction and Business Overview 71
10.3.3 Takeda Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 72
10.3.4 Takeda Human Serum Albumin Products Offered 72
10.3.5 Takeda Recent Development 73
10.4 Octapharma 75
10.4.1 Octapharma Company Information 75
10.4.2 Octapharma Introduction and Business Overview 75
10.4.3 Octapharma Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 76
10.4.4 Octapharma Human Serum Albumin Products Offered 76
10.4.5 Octapharma Recent Development 77
10.5 CBPO 77
10.5.1 CBPO Company Information 77
10.5.2 CBPO Introduction and Business Overview 78
10.5.3 CBPO Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 79
10.5.4 CBPO Human Serum Albumin Products Offered 79
10.5.5 CBPO Recent Development 80
10.6 Hualan Bio 81
10.6.1 Hualan Bio Company Information 81
10.6.2 Hualan Bio Introduction and Business Overview 81
10.6.3 Hualan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 82
10.6.4 Hualan Bio Human Serum Albumin Products Offered 83
10.7 Kedrion 84
10.7.1 Kedrion Company Information 84
10.7.2 Kedrion Introduction and Business Overview 84
10.7.3 Kedrion Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 85
10.7.4 Kedrion Human Serum Albumin Products Offered 85
10.8 Shanghai RAAS 86
10.8.1 Shanghai RAAS Company Information 86
10.8.2 Shanghai RAAS Introduction and Business Overview 87
10.8.3 Shanghai RAAS Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 88
10.8.4 Shanghai RAAS Human Serum Albumin Products Offered 88
10.8.5 Shanghai RAAS Recent Development 89
10.9 LFB Group 91
10.9.1 LFB Group Company Information 91
10.9.2 LFB Group Introduction and Business Overview 91
10.9.3 LFB Group Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 92
10.9.4 LFB Group Human Serum Albumin Products Offered 92
10.10 Biotest 93
10.10.1 Biotest Company Information 93
10.10.2 Biotest Introduction and Business Overview 94
10.10.3 Biotest Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 94
10.10.4 Biotest Human Serum Albumin Products Offered 94
10.11 Tiantan Bio 95
10.11.1 Tiantan Bio Corporation Information 95
10.11.2 Tiantan Bio Main Business Overview 96
10.11.3 Tiantan Bio Human Serum Albumin Products Offered 96
10.11.4 Tiantan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 96
10.12 Shuanglin Bio 97
10.12.1 Shuanglin Bio Corporation Information 97
10.12.2 Shuanglin Bio Main Business Overview 97
10.12.3 Shuanglin Bio Human Serum Albumin Products Offered 98
10.12.4 Shuanglin Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 98
10.13 Boya Bio 99
10.13.1 Boya Bio Corporation Information 99
10.13.2 Boya Bio Main Business Overview 99
10.13.3 Boya Bio Human Serum Albumin Products Offered 100
10.13.4 Boya Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 100
10.14 Yuanda Shuyang 101
10.14.1 Yuanda Shuyang Corporation Information 101
10.14.2 Yuanda Shuyang Main Business Overview 101
10.14.3 Yuanda Shuyang Human Serum Albumin Products Offered 102
10.14.4 Yuanda Shuyang Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 103
10.15 Weiguang Bio 103
10.15.1 Weiguang Bio Corporation Information 103
10.15.2 Weiguang Bio Main Business Overview 104
10.15.3 Weiguang Bio Human Serum Albumin Products Offered 104
10.15.4 Weiguang Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 104
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 106
11.1 Human Serum Albumin Key Raw Materials 106
11.1.1 Key Raw Materials 106
11.1.2 Raw Materials Key Suppliers 107
11.2 Manufacturing Cost Structure 109
11.2.1 Raw Materials 109
11.2.2 Labor Cost 109
11.2.3 Manufacturing Expenses 109
11.3 Human Serum Albumin Industrial Chain Analysis 110
11.4 Human Serum Albumin Market Dynamics 110
11.4.1 Human Serum Albumin Industry Trends 110
11.4.2 Human Serum Albumin Market Drivers 113
11.4.3 Human Serum Albumin Market Challenges 114
11.4.4 Human Serum Albumin Market Restraints 114
12 Marketing Strategy Analysis, Distributors 115
12.1 Sales Channel 115
12.2 Human Serum Albumin Distributors 116
12.3 Human Serum Albumin Downstream Customers 118
13 Research Findings and Conclusion 123
14 Appendix 125
14.1 Research Methodology 125
14.1.1 Methodology/Research Approach 125
14.1.2 Data Source 128
14.2 Author Details 131
14.3 Disclaimer 133

 

ページTOPに戻る


 

Summary

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Human Serum Albumin was estimated at US$ 5110 million in the year 2022, is projected to reach a revised size of US$ 8369 million by 2029, growing at a CAGR of 7.27 % during the forecast period 2023-2029.
North American market for Human Serum Albumin was valued at $ 651 million in 2022, will reach $ 986 million by 2029, at a CAGR of 6.07% during the forecast period of 2023 through 2029.
Asia-Pacific market for Human Serum Albumin was valued at $ 3507 million in 2022, will reach $ 5896 million by 2029, at a CAGR of 7.71 % during the forecast period of 2023 through 2029.
Europe market for Human Serum Albumin was valued at $ 729 million in 2022, will reach $ 1113 million by 2029, at a CAGR of 6.11 % during the forecast period of 2023 through 2029.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum Albumin.
The Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Serum Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation
This report covers the Human Serum Albumin segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio

Segment by Type
5% Concentrations
20-25% Concentrations

Segment by Application
Excipient
Therapeutics
Other

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Serum Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Serum Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.



ページTOPに戻る


Table of Contents

1 Human Serum Albumin Market Overview 1
1.1 Human Serum Albumin Product Overview 1
1.2 Human Serum Albumin Market by Type 3
1.2.1 5% Concentrations 3
1.2.2 20-25% Concentrations 5
1.3 Global Human Serum Albumin Market Size by Type 6
1.3.1 Global Human Serum Albumin Market Size Overview by Type (2018-2029) 6
1.3.2 Global Human Serum Albumin Historic Market Size Review by Type (2018-2023) 7
1.3.3 Global Human Serum Albumin Forecasted Market Size by Type (2024-2029) 9
1.4 Key Regions Market Size by Type 10
1.4.1 North America Human Serum Albumin Sales Breakdown by Type (2018-2023) 10
1.4.2 Europe Human Serum Albumin Sales Breakdown by Type (2018-2023) 11
1.4.3 Asia-Pacific Human Serum Albumin Sales Breakdown by Type (2018-2023) 13
1.4.4 South America Human Serum Albumin Sales Breakdown by Type (2018-2023) 15
1.4.5 Middle East and Africa Human Serum Albumin Sales Breakdown by Type (2018-2023) 17
2 Human Serum Albumin Market Competition by Company 19
2.1 Global Top Players by Human Serum Albumin Sales (2018-2023) 19
2.2 Global Top Players by Human Serum Albumin Revenue (2018-2023) 20
2.3 Global Top Players by Human Serum Albumin Price (2018-2023) 22
2.4 Global Top Manufacturers Human Serum Albumin Manufacturing Base Distribution, Sales Area, Product Type 23
2.5 Human Serum Albumin Market Competitive Situation and Trends 23
2.5.1 Human Serum Albumin Market Concentration Rate (2018-2023) 23
2.5.2 Global 5 and 10 Largest Manufacturers by Human Serum Albumin Revenue in 2022 24
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum Albumin as of 2022) 25
2.7 Founded Date of Key Human Serum Albumin Manufacturer 26
2.8 Mergers & Acquisitions, Expansion 27
3 Human Serum Albumin Status and Outlook by Region 30
3.1 Global Human Serum Albumin Market Size and CAGR by Region: 2018 VS 2022 VS 2029 30
3.2 Global Human Serum Albumin Historic Market Size by Region 30
3.2.1 Global Human Serum Albumin Sales in Volume by Region (2018-2023) 30
3.2.2 Global Human Serum Albumin Sales in Value by Region (2018-2023) 31
3.2.3 Global Human Serum Albumin Sales (Volume & Value), Price and Gross Margin (2018-2023) 32
3.3 Global Human Serum Albumin Forecasted Market Size by Region 32
3.3.1 Global Human Serum Albumin Sales in Volume by Region (2024-2029) 32
3.3.2 Global Human Serum Albumin Sales in Value by Region (2024-2029) 33
3.3.3 Global Human Serum Albumin Sales (Volume & Value), Price and Gross Margin (2024-2029) 33
4 Human Serum Albumin by Application 34
4.1 Human Serum Albumin Market by Application 34
4.1.1 Excipient 34
4.1.2 Therapeutics 35
4.2 Global Human Serum Albumin Market Size by Application 36
4.2.1 Global Human Serum Albumin Market Size Overview by Application (2018-2029) 37
4.2.2 Global Human Serum Albumin Historic Market Size Review by Application (2018-2023) 39
4.2.3 Global Human Serum Albumin Forecasted Market Size by Application (2024-2029) 40
4.3 Key Regions Market Size by Application 41
4.3.1 North America Human Serum Albumin Sales Breakdown by Application (2018-2023) 41
4.3.2 Europe Human Serum Albumin Sales Breakdown by Application (2018-2023) 42
4.3.3 Asia-Pacific Human Serum Albumin Sales Breakdown by Application (2018-2023) 43
4.3.4 South America Human Serum Albumin Sales Breakdown by Application (2018-2023) 44
4.3.5 Middle East and Africa Human Serum Albumin Sales Breakdown by Application (2018-2023) 45
5 North America Human Serum Albumin by Country 47
5.1 North America Human Serum Albumin Historic Market Size by Country 47
5.1.1 North America Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 47
5.1.2 North America Human Serum Albumin Sales in Volume by Country (2018-2023) 47
5.1.3 North America Human Serum Albumin Sales in Value by Country (2018-2023) 48
5.2 North America Human Serum Albumin Forecasted Market Size by Country 48
5.2.1 North America Human Serum Albumin Sales in Volume by Country (2024-2029) 48
5.2.2 North America Human Serum Albumin Sales in Value by Country (2024-2029) 49
6 Europe Human Serum Albumin by Country 50
6.1 Europe Human Serum Albumin Historic Market Size by Country 50
6.1.1 Europe Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 50
6.1.2 Europe Human Serum Albumin Sales in Volume by Country (2018-2023) 50
6.1.3 Europe Human Serum Albumin Sales in Value by Country (2018-2023) 51
6.2 Europe Human Serum Albumin Forecasted Market Size by Country 52
6.2.1 Europe Human Serum Albumin Sales in Volume by Country (2024-2029) 52
6.2.2 Europe Human Serum Albumin Sales in Value by Country (2024-2029) 53
7 Asia-Pacific Human Serum Albumin by Region 54
7.1 Asia-Pacific Human Serum Albumin Historic Market Size by Region 54
7.1.1 Asia-Pacific Human Serum Albumin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 54
7.1.2 Asia-Pacific Human Serum Albumin Sales in Volume by Region (2018-2023) 54
7.1.3 Asia-Pacific Human Serum Albumin Sales in Value by Region (2018-2023) 55
7.2 Asia-Pacific Human Serum Albumin Forecasted Market Size by Region 56
7.2.1 Asia-Pacific Human Serum Albumin Sales in Volume by Region (2024-2029) 56
7.2.2 Asia-Pacific Human Serum Albumin Sales in Value by Region (2024-2029) 57
8 South America Human Serum Albumin by Country 58
8.1 South America Human Serum Albumin Historic Market Size by Country 58
8.1.1 South America Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 58
8.1.2 South America Human Serum Albumin Sales in Volume by Country (2018-2023) 58
8.1.3 South America Human Serum Albumin Sales in Value by Country (2018-2023) 59
8.2 South America Human Serum Albumin Forecasted Market Size by Country 59
8.2.1 South America Human Serum Albumin Sales in Volume by Country (2024-2029) 59
8.2.2 South America Human Serum Albumin Sales in Value by Country (2024-2029) 60
9 Middle East and Africa Human Serum Albumin by Country 61
9.1 Middle East and Africa Human Serum Albumin Historic Market Size by Country 61
9.1.1 Middle East and Africa Human Serum Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 61
9.1.2 Middle East and Africa Human Serum Albumin Sales in Volume by Country (2018-2023) 61
9.1.3 Middle East and Africa Human Serum Albumin Sales in Value by Country (2018-2023) 62
9.2 Middle East and Africa Human Serum Albumin Forecasted Market Size by Country 62
9.2.1 Middle East and Africa Human Serum Albumin Sales in Volume by Country (2024-2029) 62
9.2.2 Middle East and Africa Human Serum Albumin Sales in Value by Country (2024-2029) 63
10 Company Profiles 64
10.1 Grifols 64
10.1.1 Grifols Company Information 64
10.1.2 Grifols Introduction and Business Overview 64
10.1.3 Grifols Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 65
10.1.4 Grifols Human Serum Albumin Products Offered 65
10.1.5 Grifols Recent Development 66
10.2 CSL 67
10.2.1 CSL Company Information 67
10.2.2 CSL Introduction and Business Overview 68
10.2.3 CSL Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 68
10.2.4 CSL Human Serum Albumin Products Offered 69
10.2.5 CSL Recent Development 69
10.3 Takeda 70
10.3.1 Takeda Company Information 70
10.3.2 Takeda Introduction and Business Overview 71
10.3.3 Takeda Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 72
10.3.4 Takeda Human Serum Albumin Products Offered 72
10.3.5 Takeda Recent Development 73
10.4 Octapharma 75
10.4.1 Octapharma Company Information 75
10.4.2 Octapharma Introduction and Business Overview 75
10.4.3 Octapharma Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 76
10.4.4 Octapharma Human Serum Albumin Products Offered 76
10.4.5 Octapharma Recent Development 77
10.5 CBPO 77
10.5.1 CBPO Company Information 77
10.5.2 CBPO Introduction and Business Overview 78
10.5.3 CBPO Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 79
10.5.4 CBPO Human Serum Albumin Products Offered 79
10.5.5 CBPO Recent Development 80
10.6 Hualan Bio 81
10.6.1 Hualan Bio Company Information 81
10.6.2 Hualan Bio Introduction and Business Overview 81
10.6.3 Hualan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 82
10.6.4 Hualan Bio Human Serum Albumin Products Offered 83
10.7 Kedrion 84
10.7.1 Kedrion Company Information 84
10.7.2 Kedrion Introduction and Business Overview 84
10.7.3 Kedrion Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 85
10.7.4 Kedrion Human Serum Albumin Products Offered 85
10.8 Shanghai RAAS 86
10.8.1 Shanghai RAAS Company Information 86
10.8.2 Shanghai RAAS Introduction and Business Overview 87
10.8.3 Shanghai RAAS Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 88
10.8.4 Shanghai RAAS Human Serum Albumin Products Offered 88
10.8.5 Shanghai RAAS Recent Development 89
10.9 LFB Group 91
10.9.1 LFB Group Company Information 91
10.9.2 LFB Group Introduction and Business Overview 91
10.9.3 LFB Group Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 92
10.9.4 LFB Group Human Serum Albumin Products Offered 92
10.10 Biotest 93
10.10.1 Biotest Company Information 93
10.10.2 Biotest Introduction and Business Overview 94
10.10.3 Biotest Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 94
10.10.4 Biotest Human Serum Albumin Products Offered 94
10.11 Tiantan Bio 95
10.11.1 Tiantan Bio Corporation Information 95
10.11.2 Tiantan Bio Main Business Overview 96
10.11.3 Tiantan Bio Human Serum Albumin Products Offered 96
10.11.4 Tiantan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 96
10.12 Shuanglin Bio 97
10.12.1 Shuanglin Bio Corporation Information 97
10.12.2 Shuanglin Bio Main Business Overview 97
10.12.3 Shuanglin Bio Human Serum Albumin Products Offered 98
10.12.4 Shuanglin Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 98
10.13 Boya Bio 99
10.13.1 Boya Bio Corporation Information 99
10.13.2 Boya Bio Main Business Overview 99
10.13.3 Boya Bio Human Serum Albumin Products Offered 100
10.13.4 Boya Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 100
10.14 Yuanda Shuyang 101
10.14.1 Yuanda Shuyang Corporation Information 101
10.14.2 Yuanda Shuyang Main Business Overview 101
10.14.3 Yuanda Shuyang Human Serum Albumin Products Offered 102
10.14.4 Yuanda Shuyang Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 103
10.15 Weiguang Bio 103
10.15.1 Weiguang Bio Corporation Information 103
10.15.2 Weiguang Bio Main Business Overview 104
10.15.3 Weiguang Bio Human Serum Albumin Products Offered 104
10.15.4 Weiguang Bio Human Serum Albumin Sales, Revenue and Gross Margin (2018-2023) 104
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 106
11.1 Human Serum Albumin Key Raw Materials 106
11.1.1 Key Raw Materials 106
11.1.2 Raw Materials Key Suppliers 107
11.2 Manufacturing Cost Structure 109
11.2.1 Raw Materials 109
11.2.2 Labor Cost 109
11.2.3 Manufacturing Expenses 109
11.3 Human Serum Albumin Industrial Chain Analysis 110
11.4 Human Serum Albumin Market Dynamics 110
11.4.1 Human Serum Albumin Industry Trends 110
11.4.2 Human Serum Albumin Market Drivers 113
11.4.3 Human Serum Albumin Market Challenges 114
11.4.4 Human Serum Albumin Market Restraints 114
12 Marketing Strategy Analysis, Distributors 115
12.1 Sales Channel 115
12.2 Human Serum Albumin Distributors 116
12.3 Human Serum Albumin Downstream Customers 118
13 Research Findings and Conclusion 123
14 Appendix 125
14.1 Research Methodology 125
14.1.1 Methodology/Research Approach 125
14.1.2 Data Source 128
14.2 Author Details 131
14.3 Disclaimer 133

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05 10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る